Meiji Yasuda Asset Management Co Ltd. Has $3.84 Million Stock Position in HCA Healthcare, Inc. $HCA

Meiji Yasuda Asset Management Co Ltd. lessened its position in HCA Healthcare, Inc. (NYSE:HCA) by 14.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,227 shares of the company’s stock after selling 1,413 shares during the period. Meiji Yasuda Asset Management Co Ltd.’s holdings in HCA Healthcare were worth $3,841,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of HCA. Viking Global Investors LP increased its holdings in HCA Healthcare by 58.5% in the 2nd quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after purchasing an additional 690,773 shares in the last quarter. Northwestern Mutual Wealth Management Co. increased its holdings in HCA Healthcare by 4,545.5% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 663,337 shares of the company’s stock worth $309,686,000 after purchasing an additional 649,058 shares in the last quarter. Danske Bank A S acquired a new position in HCA Healthcare in the 3rd quarter worth about $115,530,000. Zurich Insurance Group Ltd FI grew its position in shares of HCA Healthcare by 3,755.9% in the 3rd quarter. Zurich Insurance Group Ltd FI now owns 269,912 shares of the company’s stock valued at $115,036,000 after buying an additional 262,912 shares during the last quarter. Finally, Mondrian Investment Partners LTD bought a new stake in shares of HCA Healthcare in the 3rd quarter valued at about $106,605,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on HCA shares. Royal Bank Of Canada reduced their price target on HCA Healthcare from $593.00 to $534.00 and set an “outperform” rating on the stock in a research report on Monday, April 27th. Deutsche Bank Aktiengesellschaft reduced their price target on HCA Healthcare from $558.00 to $540.00 and set a “buy” rating on the stock in a research report on Tuesday, April 28th. Sanford C. Bernstein cut their target price on HCA Healthcare from $541.00 to $503.00 and set a “market perform” rating on the stock in a research report on Tuesday, April 28th. UBS Group upped their target price on HCA Healthcare from $598.00 to $635.00 and gave the company a “buy” rating in a research report on Monday, February 23rd. Finally, Wall Street Zen lowered HCA Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, May 2nd. Sixteen equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average target price of $515.77.

HCA Healthcare Stock Performance

Shares of NYSE:HCA opened at $394.40 on Friday. The business’s 50 day simple moving average is $465.16 and its two-hundred day simple moving average is $483.61. The firm has a market cap of $87.49 billion, a P/E ratio of 13.56, a PEG ratio of 1.24 and a beta of 1.18. HCA Healthcare, Inc. has a 52-week low of $330.00 and a 52-week high of $556.52.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.19 by ($0.04). The firm had revenue of $19.11 billion during the quarter, compared to the consensus estimate of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The firm’s revenue was up 4.3% on a year-over-year basis. During the same quarter in the previous year, the company posted $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities analysts forecast that HCA Healthcare, Inc. will post 30.07 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be paid a $0.78 dividend. The ex-dividend date of this dividend is Tuesday, June 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. HCA Healthcare’s dividend payout ratio is 10.73%.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.